Skip to main content
logo
Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
15.79
+0.23 (1.48%)
Jul 21, 2026, 1:09 PM EDT - Market open

Caris Life Sciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
907.29812.03412.26306.13258.49
Revenue Growth (YoY)
100.51%96.97%34.67%18.43%-
Cost of Revenue
137.04272.87233.48216.82178.46
Gross Profit
770.25539.17178.7889.3180.02
Selling, General & Admin
405.28392.47321.99291.98294.51
Research & Development
109.83101.58113.92116.88101.27
Total Operating Expenses
515.11494.06435.9408.86395.78
Operating Income
-17.9945.11-257.12-319.55-315.76
Interest Income
22.8316.57.1211.260.95
Interest Expense
-56.88-56.85-50.03-31.61-26.68
Other Non-Operating Income (Expense)
-40.45-72.8518.14-1.5120.66
Total Non-Operating Income (Expense)
-74.5-113.2-24.77-21.86-5.07
Pretax Income
-72.43-68.09-281.89-341.42-320.83
Provision for Income Taxes
0.13----
Net Income
-72.3-68.09-281.89-341.42-320.83
Net Income Attributable to Preferred Dividends
--96.37121.11-
Net Income to Common
-1.02-68.09-378.26-462.53-320.83
Shares Outstanding (Basic)
22816735350
Shares Outstanding (Diluted)
23516735350
Shares Change (YoY)
560.35%371.04%1.59%104626.10%-
EPS (Basic)
-7.59-3.22-10.66-13.24-12.00
EPS (Diluted)
-7.61-3.22-10.66-13.24-12.00
Free Cash Flow
123.4666.9-253.64-298.42-327.96
Free Cash Flow Growth
84.55%----
Free Cash Flow Per Share
0.520.40-7.15-8.54-9829.27
Gross Margin
84.90%66.40%43.37%29.17%30.96%
Operating Margin
-1.98%5.56%-62.37%-104.38%-122.16%
Profit Margin
-7.97%-8.38%-68.38%-111.53%-124.12%
FCF Margin
13.61%8.24%-61.52%-97.48%-126.88%
EBITDA
2.6567.73-208.21-270.55-267.5
EBITDA Margin
0.29%8.34%-50.50%-88.38%-103.49%
EBIT
-17.9945.11-257.12-319.55-315.76
EBIT Margin
-1.98%5.56%-62.37%-104.38%-122.16%
Effective Tax Rate
-0.18%0.00%0.00%0.00%0.00%
SEC Filings: 10-K · 10-Q